Trial site
The First Affiliated Hospital of Suzhou University
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease2 trials
- Acute lymphoblastic leukaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Colorectal cancer1 trial
- Hepatitis B1 trial
- Lung cancer1 trial
- Migraine1 trial
- Obesity1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- and 1 more
- Phase
- Phase 36 trials
- Phase 12 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Ascentage Pharma Group Inc.1 trial
- Beijing Continent Pharmaceutical Co, Ltd.1 trial
- Capital Medical University1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- and 6 more
Running trials
Active, not recruiting
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
Closed trials
Completed
The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers
Completed
A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function
Completed
Completed
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026